Justin Bowers
Stock Analyst at Deutsche Bank
(1.37)
# 3,575
Out of 4,512 analysts
122
Total ratings
45.5%
Success rate
-0.3%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintained: Buy | $620 → $630 | $534.07 | +17.96% | 10 | Jul 9, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | $66 → $73 | $71.23 | +2.48% | 9 | Jun 26, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $370 → $188 | $167.97 | +11.92% | 8 | Jun 25, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $17 → $23 | $45.79 | -49.77% | 9 | May 8, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintained: Buy | $10 → $6 | $6.51 | -7.83% | 6 | May 8, 2026 | |
| CON Concentra Group Holdings Parent | Maintained: Buy | $29 → $32 | $30.90 | +3.56% | 2 | May 8, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $350 | $376.39 | -7.01% | 10 | May 7, 2026 | |
| FTRE Fortrea Holdings | Maintained: Hold | $14 | $18.03 | -22.35% | 6 | May 7, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $345 → $315 | $357.65 | -11.93% | 6 | Feb 13, 2026 | |
| DHR Danaher | Maintained: Buy | $270 | $199.05 | +35.64% | 10 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $185 | $231.21 | -19.99% | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $220 | $207.83 | +5.86% | 16 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $336 → $430 | $536.17 | -19.80% | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 → $175 | $147.13 | n/a | 8 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $11.29 | n/a | 6 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $70 | $108.73 | n/a | 1 | Sep 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $191.20 | n/a | 1 | Jan 17, 2014 |
Thermo Fisher Scientific
Jul 9, 2026
Maintained: Buy
Price Target: $620 → $630
Current: $534.07
Upside: +17.96%
Bio-Techne
Jun 26, 2026
Downgraded: Hold
Price Target: $66 → $73
Current: $71.23
Upside: +2.48%
ICON Public Limited Company
Jun 25, 2026
Maintained: Buy
Price Target: $370 → $188
Current: $167.97
Upside: +11.92%
10x Genomics
May 8, 2026
Maintained: Hold
Price Target: $17 → $23
Current: $45.79
Upside: -49.77%
Maravai LifeSciences Holdings
May 8, 2026
Maintained: Buy
Price Target: $10 → $6
Current: $6.51
Upside: -7.83%
Concentra Group Holdings Parent
May 8, 2026
Maintained: Buy
Price Target: $29 → $32
Current: $30.90
Upside: +3.56%
Waters
May 7, 2026
Maintained: Hold
Price Target: $330 → $350
Current: $376.39
Upside: -7.01%
Fortrea Holdings
May 7, 2026
Maintained: Hold
Price Target: $14
Current: $18.03
Upside: -22.35%
West Pharmaceutical Services
Feb 13, 2026
Maintained: Buy
Price Target: $345 → $315
Current: $357.65
Upside: -11.93%
Danaher
Jan 29, 2026
Maintained: Buy
Price Target: $270
Current: $199.05
Upside: +35.64%
Aug 7, 2025
Maintained: Buy
Price Target: $180 → $185
Current: $231.21
Upside: -19.99%
Jul 29, 2025
Maintained: Buy
Price Target: $260 → $220
Current: $207.83
Upside: +5.86%
Jul 23, 2025
Maintained: Hold
Price Target: $336 → $430
Current: $536.17
Upside: -19.80%
Aug 16, 2024
Maintained: Buy
Price Target: $155 → $175
Current: $147.13
Upside: n/a
Jul 26, 2024
Maintained: Hold
Price Target: $25
Current: $11.29
Upside: n/a
Sep 16, 2019
Initiated Coverage: Hold
Price Target: $70
Current: $108.73
Upside: n/a
Jan 17, 2014
Maintained: Buy
Price Target: $140
Current: $191.20
Upside: n/a